{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:08:42Z","timestamp":1760044122658},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T00:00:00Z","timestamp":1377475200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0074425","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T21:19:02Z","timestamp":1377551942000},"page":"e74425","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Development of Novel Rifampicin-Derived P-Glycoprotein Activators\/Inducers. Synthesis, In Silico Analysis and Application in the RBE4 Cell Model, Using Paraquat as Substrate"],"prefix":"10.1371","volume":"8","author":[{"given":"V\u00e2nia","family":"Vilas-Boas","sequence":"first","affiliation":[]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Palmeira","sequence":"additional","affiliation":[]},{"given":"Em\u00edlia","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa Maria","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Paula S\u00e9rio","family":"Branco","sequence":"additional","affiliation":[]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Maria de Lourdes","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,8,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/DMR-120001389","article-title":"Drugs as P-glycoprotein substrates, inhibitors, and inducers","volume":"34","author":"RB Kim","year":"2002","journal-title":"Drug Metab Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"RL Juliano","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02614215","article-title":"P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine)","volume":"13","author":"DJ Adams","year":"1995","journal-title":"Invest New Drugs"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10637-010-9569-1","article-title":"Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP","volume":"30","author":"NA de Vries","year":"2012","journal-title":"Invest New Drugs"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11095-007-9376-3","article-title":"Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells","volume":"25","author":"C Hirayama","year":"2008","journal-title":"Pharm Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e59419","DOI":"10.1371\/journal.pone.0059419","article-title":"Functional impact of ABCB1 variants on interactions between P-glycoprotein and methadone","volume":"8","author":"CC Hung","year":"2013","journal-title":"PLOS ONE"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e61524","DOI":"10.1371\/journal.pone.0061524","article-title":"Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved","volume":"8","author":"AS Meena","year":"2013","journal-title":"PLOS ONE"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"AH Schinkel","year":"1996","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e60334","DOI":"10.1371\/journal.pone.0060334","article-title":"Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference","volume":"8","author":"MR Ansbro","year":"2013","journal-title":"PLOS ONE"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10637-010-9496-1","article-title":"YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway","volume":"29","author":"CC Hung","year":"2011","journal-title":"Invest New Drugs"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.1991.9.1.17","article-title":"P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil","volume":"9","author":"TP Miller","year":"1991","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI112450","article-title":"Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro","volume":"77","author":"LM Slater","year":"1986","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2004.06.002","article-title":"Importance of P-glycoprotein at blood-tissue barriers","volume":"25","author":"MF Fromm","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"F Thiebaut","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/38.9.1974900","article-title":"Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues","volume":"38","author":"C Cordon-Cardo","year":"1990","journal-title":"J Histochem Cytochem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"C Cordon-Cardo","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs","volume":"77","author":"AH Schinkel","year":"1994","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"AH Schinkel","year":"1995","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.freeradbiomed.2006.06.012","article-title":"P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity","volume":"41","author":"RJ Dinis-Oliveira","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00204-010-0587-8","article-title":"In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells","volume":"85","author":"R Silva","year":"2011","journal-title":"Arch Toxicol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2012.11.028","article-title":"Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells","volume":"217","author":"R Silva","year":"2013","journal-title":"Toxicol Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","article-title":"Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities","volume":"250","author":"AB Shapiro","year":"1997","journal-title":"Eur J Biochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","article-title":"The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin","volume":"104","author":"B Greiner","year":"1999","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.2006.02587.x","article-title":"Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements","volume":"62","author":"A Owen","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/bdd.753","article-title":"Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine","volume":"32","author":"CJ Bachmeier","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2003.10.010","article-title":"Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells","volume":"483","author":"M Magnarin","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/aps.2009.187","article-title":"Effect of prototypical inducers on ligand activated nuclear receptor regulated drug disposition genes in rodent hepatic and intestinal cells","volume":"31","author":"P Martin","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1742-7843.2012.00866.x","article-title":"Effects of rifampicin, dexamethasone, St. John\u2019s Wort and Thyroxine on maternal and foetal expression of Abcb1 and organ distribution of talinolol in pregnant rats","volume":"111","author":"K Salj\u00e9","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1039\/c2ob00008c","article-title":"Intramolecular proton transfer impact on antibacterial properties of ansamycin antibiotic rifampicin and its new amino analogues","volume":"10","author":"K Pyta","year":"2012","journal-title":"Org Biomol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10571-004-1376-9","article-title":"Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions","volume":"25","author":"F Roux","year":"2005","journal-title":"Cell Mol Neurobiol"},{"key":"ref31","first-page":"351","article-title":"Diazomethane","volume":"5","author":"JA Moore","year":"1973","journal-title":"Org Synth"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jcp.1041590114","article-title":"Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells","volume":"159","author":"F Roux","year":"1994","journal-title":"J Cell Physiol"},{"key":"ref33","article-title":"RBE4 cells are highly resistant to paraquat-induced cytotoxicity \u2013 studies on uptake and efflux mechanisms","author":"V Vilas-Boas","year":"2013","journal-title":"J Appl Toxicol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"OH Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/cyto.a.21135","article-title":"P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging","volume":"79","author":"V Vilas-Boas","year":"2011","journal-title":"Cytometry A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1747-0285.2011.01089.x","article-title":"New uses for old drugs: pharmacophore-based screening for the discovery of P-glycoprotein inhibitors","volume":"78","author":"A Palmeira","year":"2011","journal-title":"Chem Biol Drugs Des"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcp.2011.10.004","article-title":"Dual inhibitors of P-glycoprotein and tumor cell growth: (re)discovering thioxanthones","volume":"83","author":"A Palmeira","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/cmdc.200900283","article-title":"Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action","volume":"4","author":"K Sterz","year":"2009","journal-title":"Chemmedchem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1248\/bpb.31.873","article-title":"P-glycoprotein functions in peripheral-blood CD4+ cells of patients with systemic lupus erythematosus","volume":"31","author":"K Henmi","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00210-007-0177-3","article-title":"Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1\/ABCB1) activity in human peripheral blood mononuclear cells","volume":"376","author":"CH Storch","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.1021\/bi0020574","article-title":"Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1)","volume":"39","author":"R Daoud","year":"2000","journal-title":"Biochemistry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-04-1725","article-title":"Cyclosporin A is a broad-spectrum multidrug resistance modulator","volume":"11","author":"M Qadir","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1471-4159.1998.71020705.x","article-title":"Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells","volume":"71","author":"A Regina","year":"1998","journal-title":"J Neurochem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/mp200201y","article-title":"Mechanistic studies of the effect of bile salts on rhodamine 123 uptake into RBE4 cells","volume":"9","author":"L Yang","year":"2012","journal-title":"Mol Pharm"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AEM.17.2.202-207.1969","article-title":"In vitro effect of rifampin on mycobacteria","volume":"17","author":"V Lorian","year":"1969","journal-title":"Appl Microbiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5688.89","article-title":"Experimental and clinical studies on rifampicin in treatment of leprosy","volume":"1","author":"RJ Rees","year":"1970","journal-title":"BMJ"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1086\/518655","article-title":"Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome","volume":"196","author":"H McIlleron","year":"2007","journal-title":"J Infect Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.93.9.4001","article-title":"P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans","volume":"93","author":"EG Schuetz","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0006-2952(96)00826-X","article-title":"Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein","volume":"53","author":"AB Shapiro","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","article-title":"Communication between multiple drug binding sites on P-glycoprotein","volume":"58","author":"C Martin","year":"2000","journal-title":"Mol Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/07357909309020260","article-title":"Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells","volume":"11","author":"AR Safa","year":"1993","journal-title":"Cancer Invest"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0076-6879(98)92023-7","article-title":"Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein","volume":"292","author":"AR Safa","year":"1998","journal-title":"Methods Enzymol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011043482142","article-title":"Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators","volume":"4","author":"AR Safa","year":"2004","journal-title":"Curr Med Chem Anti Cancer Agents"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"24074","DOI":"10.1074\/jbc.M109.023267","article-title":"Identification of residues in the drug translocation pathway of the human multidrug resistance P-glycoprotein by arginine mutagenesis","volume":"284","author":"TW Loo","year":"2009","journal-title":"J Biol Chem"},{"key":"ref55","article-title":"Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin","author":"V Vilas-Boas","year":"2013","journal-title":"Toxicol Lett"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0074425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T07:33:34Z","timestamp":1715931214000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0074425"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Cavalli","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,8,26]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0074425","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,26]]}}}